AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

CQS New City High Yield Fund Ltd

Share Issue/Capital Change Nov 28, 2025

10464_sha_2025-11-28_2e253cd7-417b-4942-be18-e43c65023ad9.html

Share Issue/Capital Change

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 5250J

CQS New City High Yield Fund Ltd

28 November 2025

28 November 2025

CQS New City High Yield Fund Limited

(the Company)

Issue of Equity

On 28 November 2025, the Company agreed to issue 2,500,000 ordinary shares of no par value from its blocklisting facility at a price of 50.8 pence per share. The shares will be issued for cash on 2 December 2025.

On 28 November 2025, the Company's issued share capital will consist of 650,101,858 ordinary shares and there are no shares held in treasury. Therefore, the total number of voting rights in the Company will be 650,101,858 as of 2 December 2025.

The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest, or a change to their interest, in the Company under the FCA's Disclosure Guidance and Transparency Rules.

ENQUIRIES

For the Investment Manager

Manulife |CQS Investment Management

Craig Cleland

0207 201 5368

For the Company Secretary and Administrator

BNP Paribas S.A., Jersey Branch

Guerhardt Lamprecht

01534 813 959

For the Broker

Singer Capital Markets LLP

James Maxwell / James Moat (Corporate Finance)

Alan Geeves (Sales)

020 7496 3000

For the Public Relations Adviser

TB Cardew

Tania Wild

020 7930 0777

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

IOEDVLFLEFLXFBX

Talk to a Data Expert

Have a question? We'll get back to you promptly.